15659504false2024-04-182025-04-30http://www.companieshouse.gov.uk/2024-04-17http://www.companieshouse.gov.uk/cd:Director12024-04-182025-04-30http://www.companieshouse.gov.uk/pt:PlantMachinery2025-04-30http://www.companieshouse.gov.uk/pt:ShareCapital2025-04-30http://www.companieshouse.gov.uk/cd:Director22024-04-182025-04-30http://www.companieshouse.gov.uk/pt:SharePremium2025-04-30http://www.companieshouse.gov.uk/cd:Director32024-04-182025-04-30http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12024-04-182025-04-30http://www.companieshouse.gov.uk/pt:ToolsEquipment2025-04-30http://www.companieshouse.gov.uk/cd:RegisteredOffice2024-04-182025-04-30http://www.companieshouse.gov.uk/cd:OrdinaryShareClass22024-04-182025-04-30http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2024-04-182025-04-30http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2025-04-30http://www.companieshouse.gov.uk/2024-04-182025-04-30http://www.companieshouse.gov.uk/cd:FRS1022024-04-182025-04-30http://www.companieshouse.gov.uk/2025-04-30http://www.companieshouse.gov.uk/cd:FullAccounts2024-04-182025-04-30http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2024-04-182025-04-30iso4217:GBPxbrli:sharesxbrli:pure

Registered number: 15659504

Icosphere Biosciences Ltd

ACCOUNTS

FOR THE 378 DAY PERIOD ENDED 30 APRIL 2025

Prepared By:

Barnes4Business Limited

Chartered Certified Accountants

12 Murdock Road

Bicester

Oxfordshire

OX26 4PP

Icosphere Biosciences Ltd

ACCOUNTS

FOR THE 378 DAY PERIOD ENDED 30 APRIL 2025

DIRECTORS

Dr Ryan Cawood

Dr Leonard Seymour

Dr Robert Hornby

REGISTERED OFFICE

Bioescalator Roosevelt Drive

Headington

Oxford

OX3 7FZ

COMPANY DETAILS

Private company limited by shares registered in EW - England and Wales, registered number 15659504

ACCOUNTANTS

Barnes4Business Limited

Chartered Certified Accountants

12 Murdock Road

Bicester

Oxfordshire

OX26 4PP

Icosphere Biosciences Ltd

ACCOUNTS
FOR THE378 DAY PERIODENDED30 APRIL 2025
CONTENTS
		Page
Directors' Report		-
Accountants' Report		-
Statement Of Comprehensive Income		-
Balance Sheet		3
Notes To The Accounts		4
The following do not form part of the statutory financial statements:
Trading And Profit And Loss Account		-
Profit And Loss Account Summaries		-

Icosphere Biosciences Ltd

BALANCE SHEET AT 30 April 2025
						2025
		Notes				£
FIXED ASSETS
Tangible assets		3				7,645
CURRENT ASSETS
Debtors		4		4,039
Cash at bank and in hand				163,138
				167,177
CREDITORS: Amounts falling due within one year		5		8,477
NET CURRENT ASSETS						158,700
TOTAL ASSETS LESS CURRENT LIABILITIES						166,345
CAPITAL AND RESERVES
Called up share capital		6				5
Share premium account		7				274,115
Profit and loss account						(107,775)
SHAREHOLDERS' FUNDS						166,345
For the year ending 30 April 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have decided not to deliver to the registrar a copy of the company's profit and loss account.
Approved by the board on 23 December 2025 and signed on their behalf by
.............................
Dr Ryan Cawood
Director

Icosphere Biosciences Ltd

NOTES TO THE ACCOUNTS

FOR THE 378 DAY PERIOD ENDED 30 APRIL 2025

1. ACCOUNTING POLICIES

1a. Basis Of Accounting

The accounts have been prepared under the historical cost convention.

The accounts have been prepared in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 .

1b. Depreciation
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.
Plant and Machinery		straight line 33.33%
Equipment		straight line 33.33%

2. EMPLOYEES
				2025
				No.		No.
Average number of employees				3

3. TANGIBLE FIXED ASSETS
		Plant and
		Machinery		Equipment		Total
		£		£		£
Cost
Additions		7,795		499		8,294
At 30 April 2025		7,795		499		8,294
Depreciation
For the 378 day period		629		20		649
At 30 April 2025		629		20		649
Net Book Amounts
At 30 April 2025		7,166		479		7,645

Icosphere Biosciences Ltd

4. DEBTORS				2025
				£
Amounts falling due within one year
VAT				4,039
				4,039

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
				2025
				£
Trade creditors				7,988
Pension schemes				89
Accruals				400
				8,477

6. SHARE CAPITAL				2025
				£
Allotted, issued and fully paid:
400,000 Ordinary shares of £0.00001 each				4
87,000 Ordinary A shares of £0.00001 each				1
				5
New shares issued during period:
400,000 Ordinary shares of £0.00001 each				4
87,000 Ordinary A shares of £0.00001 each				1
				5

7. SHARE PREMIUM ACCOUNT				2025
				£
Share premium account				274,115